← All stories
Markets

STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed

1 source ·1 article ·1h ago

China has tightened regulations on investigator-initiated trials, with consequences not just for Chinese researchers but some Americans, too.

Covered by 1 outlet

All coverage · 1 article